# ğŸ“… Daily Report - 2025-11-01

> ä»Šæ—¥ç­›é€‰å‡º **31** æ¡å†…å®¹ï¼Œæ¥è‡ª **5** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ“° å…¬ä¼—å·

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
è‚¿ç˜¤ç¥ç»æµ¸æ¶¦æ˜¯è¿‘æœŸç ”ç©¶çƒ­ç‚¹ï¼Œå¤šé¡¹é«˜åˆ†ç ”ç©¶ï¼ˆCancer Cell, Nature, SCIENCE ADVANCESï¼‰æ­ç¤ºå…¶ä¿ƒç™Œæœºåˆ¶ã€ä¸æŠ—PD-1æ²»ç–—å“åº”ä¸ä½³çš„å…³è”ï¼Œå¹¶ç»“åˆå•ç»†èƒã€ç©ºè½¬ç­‰æŠ€æœ¯è¿›è¡Œæ·±å…¥è§£æã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è‚¿ç˜¤ç¥ç»æµ¸æ¶¦çš„ä¿ƒç™Œæœºåˆ¶åŠå¯¹æ²»ç–—å“åº”çš„å½±å“
- ç”Ÿç‰©åŠ›å­¦è°ƒæ§åœ¨è‚¿ç˜¤ä¸­çš„ä½œç”¨åŠæ ¸å¿ƒåŸºå› è¯†åˆ«
- Dicerä½œä¸ºåˆ†å­æ¢çº½åœ¨åè°ƒè½¬å½•ã€å¤åˆ¶ä¸ä¿®å¤ä¸­çš„åŠŸèƒ½

**æŠ€æœ¯äº®ç‚¹**ï¼š
- RåŒ…Ragasåœ¨å•ç»†èƒèšç±»åˆ†æåŠå¯è§†åŒ–ä¸­çš„åº”ç”¨
- drug2cellå·¥å…·é¢„æµ‹å•ç»†èƒäºšç¾¤ä¸è¯ç‰©é¶ç‚¹
- SATURNå®ç°è·¨ç‰©ç§å•ç»†èƒæ•°æ®é›†æ•´åˆ

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
PURE-seqæŠ€æœ¯é›†æˆFACSä¸PIP-seqï¼Œå®ç°è¶…ç¨€æœ‰ç»†èƒå•ç»†èƒåŸºå› ç»„å­¦åˆ†æï¼›LRRK2-G2019Så˜å¼‚å½±å“å¸•é‡‘æ£®ç—…ä¸­ç¥ç»èƒ¶è´¨ç»†èƒç‚ç—‡åŠå¤šå·´èƒºèƒ½ç¥ç»å…ƒé€€åŒ–ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- åŸºå› ç–—æ³•åœ¨è„“æ¯’ç—‡ä¸­é€šè¿‡é‡ç¼–ç¨‹è„¾è„å’Œè‚ºéƒ¨åŸºå› ï¼Œå¢å¼ºæŠ—èŒå…ç–«å’Œå­˜æ´»ç‡ã€‚
- æ¢ç´¢ç”²çŠ¶è…ºæ¿€ç´ ç³»ç»Ÿå¹²æ‰°ç‰©å¯¹æµ·é©¬ä½“å‘è‚²æ€§ç”²çŠ¶è…ºåŠŸèƒ½å‡é€€çš„è½¬å½•ç»„å­¦å½±å“ã€‚
- SF3B1å‰ªæ¥å› å­åŸºå› æ–°å˜å¼‚ä¸ç¥ç»å‘è‚²éšœç¢çš„å…³è”ç ”ç©¶ã€‚
- UPF1è¡¨è¾¾é™ä½åœ¨é¼»å’½ç™Œä¸­ä¿ƒè¿›è‚¿ç˜¤è¿›å±•ã€‚
- FoxP3è½¬å½•å› å­äºŒèšåŒ–å’Œå¤šèšåŒ–çš„ååŒä½œç”¨ã€‚
- DHAå¯¹äººè½¯éª¨ç»†èƒçš„è½¬å½•ç»„å­¦è°ƒæ§æ•ˆåº”ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- PURE-seqï¼šé›†æˆFACSå’ŒPIP-seqï¼Œå®ç°å•ç»†èƒåŸºå› ç»„å­¦åˆ†æã€‚
- å•ç»†èƒATACæµ‹åºï¼šç”¨äºç»“ç›´è‚ è‚¿ç˜¤åŠç™Œæ—éç™Œç»„ç»‡çš„åŸºå› ç»„ç»“åˆ/å ç”¨è°±åˆ†æã€‚

### ğŸ”¬ æœŸåˆŠæ–‡ç« 

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
ç‹„è¯ºå¡éº¦åœ¨å¤å‘/éš¾æ²»æ€§éª¨è‚‰ç˜¤æ‚£è€…ä¸­å±•ç°å‡ºæ”¹å–„ç–¾ç—…æ§åˆ¶çš„æ½œåŠ›ï¼›å¾ªç¯è‚¿ç˜¤ DNA (ctDNA) æ°´å¹³åŠå…¶åŠ¨æ€å˜åŒ–å¯ä½œä¸ºæ™šæœŸä¹³è…ºç™Œæ‚£è€…é¢„åå’Œæ²»ç–—ååº”çš„é¢„æµ‹æŒ‡æ ‡ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è¯„ä¼° RANKL æŠ—ä½“ç‹„è¯ºå¡éº¦åœ¨å¤å‘/éš¾æ²»æ€§éª¨è‚‰ç˜¤æ‚£è€…ä¸­çš„ç–—æ•ˆã€‚
- ç ”ç©¶ ctDNA åŸºçº¿æ°´å¹³åŠæ²»ç–—åŠ¨æ€å˜åŒ–å¯¹æ™šæœŸä¹³è…ºç™Œæ‚£è€…é¶å‘æ²»ç–—å’Œè”åˆæ²»ç–—çš„é¢„ååŠé¢„æµ‹ä»·å€¼ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- é‡‡ç”¨å•è‡‚å¼€æ”¾æ ‡ç­¾ 2 æœŸè¯•éªŒè®¾è®¡ï¼Œä»¥å†å²æ•°æ®ä½œä¸ºåŸºçº¿è¿›è¡Œæ¯”è¾ƒã€‚
- ç»“åˆçªå˜é¶å‘æ²»ç–—å’Œç‰¹å®šè”åˆç–—æ³•ï¼ˆå¦‚å¥¥æ‹‰å¸•å°¼+ceralasertibï¼‰ï¼Œå¹¶å¯†åˆ‡ç›‘æµ‹ ctDNA æ°´å¹³å˜åŒ–ã€‚

### ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æœ¬æ–‡ä»‹ç»äº†åŸºå°¼ç³»æ•°ï¼ˆGini Indexï¼‰çš„æ¦‚å¿µåŠå…¶è®¡ç®—æ–¹æ³•ï¼Œä¸ºç†è§£å’Œé‡åŒ–ä¸å¹³ç­‰ç°è±¡æä¾›äº†ä¸€ä¸ªåŸºç¡€å·¥å…·ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
-  ç»æµå­¦é¢†åŸŸï¼Œç”¨äºè¡¡é‡æ”¶å…¥æˆ–è´¢å¯Œåˆ†é…çš„ä¸å¹³ç­‰ç¨‹åº¦ã€‚
-  ç”Ÿç‰©å­¦é¢†åŸŸï¼Œå¯ç”¨äºåˆ†æåŸºå› è¡¨è¾¾ã€ç‰©ç§å¤šæ ·æ€§ç­‰åˆ†å¸ƒçš„å‡åŒ€æ€§ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
-  åŸºå°¼ç³»æ•°æä¾›äº†ä¸€ä¸ªæ ‡å‡†åŒ–ã€ç›´è§‚çš„æŒ‡æ ‡ï¼Œç”¨äºæ¯”è¾ƒä¸åŒç¾¤ä½“æˆ–æ—¶é—´ç‚¹çš„ä¸å¹³ç­‰æ°´å¹³ã€‚

### ğŸ§ª åšå®¢æ›´æ–°

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æ–°å‹è®¡ç®—å·¥å…·SCSESé¦–æ¬¡å®ç°äº†å•ç»†èƒåˆ†è¾¨ç‡ä¸‹çš„å‰ªæ¥å¼‚è´¨æ€§è§£æï¼Œä»¥åŠsysVIå…‹æœäº†å¤šæºRNA-seqæ•°æ®æ•´åˆçš„æ‰¹é‡æ•ˆåº”éš¾é¢˜ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- å•ç»†èƒRNAæµ‹åºæŠ€æœ¯åœ¨è§£æç»†èƒå¤šæ ·æ€§å’Œè¡°è€å¯¹å…ç–«ååº”å½±å“æ–¹é¢çš„åº”ç”¨ã€‚
- å¼€å‘å’Œä¼˜åŒ–è®¡ç®—å·¥å…·ä»¥æé«˜RNAæµ‹åºæ•°æ®åˆ†æçš„å‡†ç¡®æ€§å’Œæ•´åˆèƒ½åŠ›ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- SCSESï¼šå¢å¼ºRNAæµ‹åºæ•°æ®ï¼Œç²¾ç¡®æ£€æµ‹é€‰æ‹©æ€§å‰ªæ¥ï¼Œæ­ç¤ºç»†èƒå¤šæ ·æ€§ã€‚
- sysVIï¼šæœºå™¨å­¦ä¹ æ–¹æ³•ï¼Œæœ‰æ•ˆæ•´åˆå…·æœ‰æ˜¾è‘—æ‰¹é‡æ•ˆåº”çš„å•ç»†èƒRNA-seqæ•°æ®é›†ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (11æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **é™¢å£«å›¢é˜Ÿåˆšå‘è¡¨åœ¨Cancer Cellï¼Œç»“åˆå•ç»†èƒå’Œç©ºè½¬æ­ç¤ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¿ƒç™Œæœºåˆ¶ã€‚å¤§çƒ­ç‚¹ä¸å®¹é”™è¿‡ï¼**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°è¯¾å ‚
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€cancerã€å•ç»†èƒ
- ğŸ“ **æè¿°**ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&mid=2247503778&idx=3&sn=ae63d3e008e807a728b1d19848cd1e37)

**2.** â­ **æ‹’ç»åƒç¯‡ä¸€å¾‹ï¼RåŒ…Ragaså¸¦ä½ æ‰“å¼€å•ç»†èƒèšç±»åˆ†æåŠå¯è§†åŒ–çš„æ–°å¤§é—¨**
- âœï¸ **ä½œè€…**ï¼šäº‘ç”Ÿä¿¡
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒã€RåŒ…ã€èšç±»
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&mid=2247498378&idx=1&sn=4edfc73743059e645880eb7f6b4eb46c)

**3.** **æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼ŒåŸºäºç”Ÿä¿¡åˆ†æè¯†åˆ«ç”Ÿç‰©åŠ›å­¦è°ƒæ§ç›¸å…³æ ¸å¿ƒåŸºå› å¹¶éªŒè¯ï¼è‚¿ç˜¤çš„ç¡¬åº¦æˆä¸ºç›®å‰ç ”ç©¶çš„çƒ­ç‚¹ä¹‹ä¸€!**
- âœï¸ **ä½œè€…**ï¼šä¸œæ™“ç”Ÿç‰©
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&mid=2247492972&idx=1&sn=7de79c6050e75215966cdf9401562625)

**4.** **7.7åˆ†1åŒºç”Ÿä¿¡ï¼Œå…¨æ–‡32ä¸ªFigureèšç„¦æœ€æ–°çƒ­ç‚¹ï¼šè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ã€‚å°ç¼–è®¤è¯çš„é«˜è´¨é‡ç”Ÿä¿¡æ–‡ç« ï¼ŒæŠ•ç¨¿åˆ°æ¥æ”¶ä»…ä¸¤ä¸ªå¤šæœˆï¼**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°è¯¾å ‚
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡
- ğŸ“ **æè¿°**ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&mid=2247503778&idx=4&sn=6220191106cda57014af7b113be8fbf7)

**5.** **48.5åˆ†ï¼Œæ˜Ÿçº§çƒ­ç‚¹ï¼Œåˆšå‘å®ŒCancer cellåˆæ¥ä¸ªNatureï¼Œè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¸æŠ— PD-1 æ²»ç–—å“åº”ä¸ä½³ç›¸å…³ï¼**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°è¯¾å ‚
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€cancer
- ğŸ“ **æè¿°**ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&mid=2247503778&idx=2&sn=4eafa0f3170b7331a40635e65dba1a29)

**6.** **æ¯ä¸€ä¸ªå•ç»†èƒumapå›¾éƒ½å¸¦ä¸€æ ¹å°çš®é­æ˜¯ä»€ä¹ˆé¬¼ï¼Ÿ**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡æŠ€èƒ½æ ‘
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ“ **æè¿°**ï¼šåœ¨ç¾¤é‡Œçœ‹åˆ°ä¸‡èƒ½çš„ç¾¤å‹åˆ†äº«äº†ä¸€ç¯‡æ–‡çŒ®ï¼Œæ¥è‡ªé«˜åˆ†æ‚å¿—SCIENCE ADVANCESï¼Œ2020å¹´å‘è¡¨çš„ï¼Œæ–‡çŒ®æ ‡é¢˜ä¸ºã€ŠSingle-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosisã€‹ã€‚æ¯ä¸€ä¸ªumapå›¾éƒ½æœ‰ä¸€æ ¹ç»†ä¸ä¸€æ ·çš„å‡ºç°åœ¨å›¾é‡Œé¢ï¼Œä¸Šä¸€æ¬¡çœ‹åˆ°è¿™ä¹ˆè¯¡å¼‚çš„å›¾è¿˜æ˜¯è¿™é‡Œï¼šç”»å‡ºåƒçƒŸèŠ±ä¸€æ ·çš„å•ç»†èƒumapå›¾ï¼ŒåŸå› ç«Ÿç„¶æ˜¯ï¼Ÿ å‡ºç°è¿™ç§å›¾å¯èƒ½æ˜¯å› ä¸ºä»€ä¹ˆåŸå› ï¼Ÿ æ­¤å¤–ï¼Œæˆ‘ä»¬æŠ€èƒ½æ ‘æœ€æ–°ä¸€æœŸç”Ÿä¿¡å…¥é—¨å°±åœ¨11æœˆ3å·å¼€è¯¾ï¼Œè¿˜æ²¡ä¸Šè½¦çš„å¯ä»¥çœ‹ä¸€çœ‹ç„ä¸€ç„ï¼Œè¯¦ç»†ä»‹ç»é¡µé¢å¯ä»¥ç‚¹å‡»ï¼šç”Ÿä¿¡å…¥é—¨&æ•°æ®æŒ–æ˜çº¿ä¸Šç›´æ’­è¯¾11æœˆç­ï¼Œå®Œå…¨é€‚åˆ0åŸºç¡€å°ç™½ã€‚
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&mid=2247546586&idx=1&sn=0312f9d1787ce8fcfa8cb4021de965a9)

**7.** **PYthonä¸­drug2cellé¢„æµ‹å•ç»†èƒäºšç¾¤ä¸è¯ç‰©é¶ç‚¹**
- âœï¸ **ä½œè€…**ï¼šå•ç»†èƒå¤©åœ°
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ“ **æè¿°**ï¼šdrug2cellï¼Œè¯¥å·¥å…·èƒ½å¤Ÿæ•´åˆå¦‚ChEMBLç­‰æ•°æ®åº“ä¸­çš„è¯ç‰©â€‘é¶ç‚¹å¯¹ä¿¡æ¯ï¼Œå¹¶é€šè¿‡å®šé‡ç”Ÿç‰©æ´»æ€§æŒ‡æ ‡ã€è¯ç‰©ç±»åˆ«å’Œé¶åˆ†å­ç±»åˆ«è¿›è¡Œå¤šçº§ç­›é€‰ã€‚é€šè¿‡è®¡ç®—è¯ç‰©è¯„åˆ†
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&mid=2247533415&idx=1&sn=200ab29efd97660990e00f242799be00)

**8.** **SATURNï¼šè·¨ç‰©ç§çš„å•ç»†èƒæ•°æ®é›†æ•´åˆ**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡èœé¸Ÿå›¢
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&mid=2247537835&idx=1&sn=0cbabfeb542a23e71c43d6006f63a6fc)

**9.** **10+ç”Ÿä¿¡ï¼ŒåŸºäº Ro/e å‘ç°ä¸åŒæ²»ç–—ååº”æ‚£è€… CD8Teff ç»†èƒæ¯”ä¾‹å·®å¼‚ã€‚ç»†èƒä¸°åº¦åˆ†æè¯†åˆ«å…³é”®ç»†èƒç›®å‰åœ¨é«˜åˆ†æ–‡ç« ä¸­å¾ˆå¸¸è§ï¼**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°è¯¾å ‚
- ğŸ·ï¸ **å…³é”®è¯**ï¼šç”Ÿä¿¡
- ğŸ“ **æè¿°**ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&mid=2247503778&idx=1&sn=34c3c7a10a89f1db6c862e97621c7e33)

**10.** **å¤§ä½¬ä¸€æŠ˜è…¾ï¼Œä½ å­¦å•ç»†èƒçš„éš¾åº¦åˆå¢åŠ äº†ï¼Œä½†æˆ‘ä¼šæ•‘ä½ **
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡æ˜Ÿçƒ
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzU4NjU4ODQ2MQ==&mid=2247497249&idx=1&sn=0d82615be5b2ae42d4b638281f1f95c1)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 1 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-å…¬ä¼—å·)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (14æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **GSE308045 The Peptide Genomic Therapy Increases Antibacterial Immunity and Survival in Sepsis by Reprograming the Gene Orthologs of Human Immunodeficiencies in the Spleen and Lungs**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€metabolomeã€metabolomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering
- ğŸ“ **æè¿°**ï¼šContributors : Huan Qiao ; Jozef Zienkiewicz ; Yan Liu ; Jacek HawigerSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSepsis is a life-threatening complication of infections afflicting 49 million patients worldwide with 11 million sepsis-related deaths. In the USA, this growing public health problem concerns 1.7 million adult and pediatric patients. An estimated 1 million patients with asplenia or hyposplenia are particularly vulnerable to sepsis. As the sp...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308045)

**2.** â­ **GSE246890 Putative indicators of thyroid hormone system disruption - a transcriptional footprint of developmental hypothyroidism in hippocampus**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Louise RamhÃ¸j ; Bertrand Evrard ; FrÃ©dÃ©ric ChalmelSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusThyroid hormone (TH) system disrupting compounds can impair brain development by perturbing TH action during critical life stages. Human exposure to TH system disrupting chemicals is therefore of great concern. To better protect humans against such chemicals, sensitive test methods that can detect effects on the developing brain are critical...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246890)

**3.** â­ **GSE282494 The Parkinsonâ€™s disease associated LRRK2-G2019S variant restricts serine metabolism leading to microglia inflammation and dopaminergic neuron degeneration**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€genomeã€proteomeã€metabolomeã€Seuratã€epigeneticã€epigenomeã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Henry Kurniawan ; Sarah L. Nickels ; Alise Zagare ; Elisa Zuccoli ; Enrico Glaab ; Jens C SchwambornSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensA mounting body of evidence reveals that inflammation is a major hallmark in the pathophysiology of Parkinsonâ€™s disease (PD). Notably, microglia are key players in orchestrating neuroinflammatory signalling pathways in the brain. However, the molecular mechanisms underlying the microglial response...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282494)

**4.** â­ **GSE273803 PURE-seq Integrates FACS and PIP-seq for Single-Cell Genomics of Ultra-rare Cells**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€ATAC-seqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€epigenome
- ğŸ“ **æè¿°**ï¼šContributors : Sixuan Pan ; Kai-Chun Chang ; InÃ©s FernÃ¡ndez-MaestreSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusWe used PURE-seq with single-cell RNA-sequencing (scRNA-seq) to study murine long-term hematopoietic stem cells (LT-HSCs) and their transcriptomes in the context of hematopoietic aging.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273803)

**5.** â­ **GSE287369 Novel variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€proteomeã€epigenomeã€histoneã€enrichment
- ğŸ“ **æè¿°**ï¼šContributors : Delphine Bernard ; Kevin Uguen ; Tiffany Bergot ; SolÃ¨ne Chapalain ; Marie-Pier Scott-BoyerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensSF3B1 is an essential and ubiquitous splicing factor that plays a pivotal role in the early steps of pre-mRNA splicing. Recurrent somatic missense mutations in SF3B1 are frequent in cancers, but no constitutional variant has been reported so far. We describe here a cohort of 26 individuals with neurodevelo...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287369)

**6.** â­ **GSE306105 Widespread low-affinity motifs enhance chromatin accessibility and regulatory potential in mESCs**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€histone
- ğŸ“ **æè¿°**ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306105)

**7.** â­ **GSE305669 Reduced expression of UPF1 promotes tumor progression through stabilizing COX-2 mRNA in nasopharyngeal carcinoma**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€genomeã€genomicsã€proteomeã€Scanpyã€epigenome
- ğŸ“ **æè¿°**ï¼šContributors : Chun Wu ; Ruowen Xiao ; Rui Sun ; Shijuan MaiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusNonsense-mediated mRNA decay (NMD) is conserved mRNA surveillance pathway that targeted and degraded one-third of aberrant and non-aberrant cellular transcripts. Recently, growing evidences have shown that NMD pathway is implicated in multiple cancer types. However, the activity and function of NMD in nasopharyngeal carcinoma (NPC) remains unclear. He...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305669)

**8.** â­ **GSE306459 Single-cell nucleus ATAC sequencing on colorectal tumor and adjacent nonmalignant tissues**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€sequencingã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€genomeã€Seurat
- ğŸ“ **æè¿°**ï¼šContributors : Andrew J Lee ; Inkyung Jung ; Woong-Yang ParkSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensSingle-cell ATAC sequencing data were collected from 24 colorectal tumor and 9 adjacent nonmalignant tissues pooled into 15 libraries. This dataset was generated to investigate the global chromatin accessibility profiles of epithelial, stromal, and immune cells in the colorectal cancer microenvironment. Information on the donors, tissues...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306459)

**9.** â­ **GSE299754 High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human disease**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€Visiumã€genomeã€genomicsã€Seuratã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Ludmila Szabova ; Lucy Lu ; Melanie B Gordon ; Kristine Johnson ; Theresa M Guerin ; Laura Bassel ; Deborah B Householder ; Margalie Edouard ; Amy Ries ; Serguei Kozlov ; Keith Collins ; Wendi Custer ; Kathleen Cho ; Goli Samimi ; Robert Shoemaker ; Zoe Weaver OhlerSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWe have developed novel genetically engineered mouse models for high-grade serous carcinoma of the ovary. We compare expression prof...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299754)

**10.** â­ **GSE294472 Cooperativity between head-to-head dimerization and head-to-tail multimerization of FoxP3 transcription factor**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€genomeã€proteomeã€Seurat
- ğŸ“ **æè¿°**ï¼šContributors : Fangwei Leng ; Ryan Clark ; Wenxiang Zhang ; Thibault Viennet ; Haribabu Arthanari ; Xi Wang ; Sun HurSeries Type : OtherOrganism : Mus musculusFoxP3, an essential transcription factor for regulatory T cells (Tregs), forms higher-order multimers on TnG microsatellites in the genome. Although a previous study has shown that FoxP3 can form head-to-head (H-H) dimers on inverted repeats of forkhead motifs (IR-FKHM), in vivo evidence for this configuration was elusive. An unbiased FoxP...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294472)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 4 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-æ•°æ®å‰æ²¿)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (2æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰

**1.** **RANKL æŠ—ä½“ç‹„è¯ºå¡éº¦åœ¨ä¸¤ç»„å¤å‘/éš¾æ²»æ€§éª¨è‚‰ç˜¤æ‚£è€…ä¸­çš„ 2 æœŸè¯•éªŒï¼Œå„¿ç«¥è‚¿ç˜¤å­¦ç»„ ï¼ˆCOGï¼‰ çš„æŠ¥å‘Š**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤
- ğŸ“ **æè¿°**ï¼šSecret hovertext: èƒŒæ™¯ï¼šå°é¼ æ¨¡å‹è¯æ˜äº† RANK åŠå…¶é…ä½“ RANKL åœ¨éª¨è‚‰ç˜¤ä¸­çš„ä½œç”¨ã€‚è¿™é¡¹å•è‡‚å¼€æ”¾æ ‡ç­¾ 2 æœŸè¯•éªŒçš„ä¸»è¦ç›®çš„æ˜¯ç¡®å®šç›¸å¯¹äºä»å†å² COG ä¸´åºŠè¯•éªŒæ•°æ®å¾—å‡ºçš„åŸºå‡†ï¼Œç‹„è¯ºå¡éº¦ï¼ˆä¸€ç§ RANKL å•å…‹éš†æŠ—ä½“ï¼‰æ˜¯å¦èƒ½æ”¹å–„å¤å‘æ€§éª¨è‚‰ç˜¤çš„ç–¾ç—…æ§åˆ¶ã€‚æ‚£è€…å’Œæ–¹æ³•ï¼š11-49 å²ä¸”æ‚£æœ‰å¯æµ‹é‡ç–¾ç—…çš„éª¨éª¼æˆç†Ÿæ‚£è€…ç¬¦åˆé˜Ÿåˆ— 1 çš„æ¡ä»¶ï¼Œæˆ–æ‰€æœ‰ç–¾ç—…éƒ¨ä½å®Œå…¨æ‰‹æœ¯åˆ‡é™¤çš„æ‚£è€…ç¬¦åˆé˜Ÿåˆ— 2 çš„æ¡ä»¶ã€‚æ‚£è€…æ¯ 4 å‘¨çš®ä¸‹æ³¨å°„ç‹„è¯ºå¡éº¦ 120 mgï¼Œå¹¶è¡¥å……é’™å’Œç»´ç”Ÿç´  Dã€‚é˜Ÿåˆ— 1 çš„ä¸»è¦ç»ˆç‚¹æ˜¯ RECIST ååº”å’Œ 4 ä¸ªæœˆçš„æ— äº‹ä»¶çŠ¶æ€ï¼Œé˜Ÿåˆ— 2 çš„ 12 ä¸ªæœˆæ— äº‹ä»¶çŠ¶æ€ã€‚æ¯’æ€§ã€è¯ä»£åŠ¨åŠ›å­¦å’Œè¯æ•ˆå­¦æ•ˆåº”æ˜¯å…¶ä»–ç»ˆç‚¹ã€‚ç»“æœï¼šé˜Ÿåˆ— 1 ä¸­çš„ 15 åæ‚£è€…å’Œé˜Ÿåˆ— 2 ä¸­çš„ 38 åæ‚£è€…ç¬¦åˆä¸»è¦ç»ˆç‚¹çš„æ¡ä»¶å¹¶å¯è¯„ä¼°ã€‚15 åé˜Ÿåˆ— 1 æ‚£è€…ä¸­çš„ä¸€ååœ¨ 4 ä¸ªæœˆæ—¶ä¿æŒæ— äº‹ä»¶ã€‚æ²¡æœ‰å®¢è§‚çš„å›åº”ã€‚38 åé˜Ÿåˆ— 2 æ‚£è€…ä¸­æœ‰ 10 ååœ¨ 12 ä¸ªæœˆæ—¶æ— äº‹
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://m.x-mol.com/paper/1983669132093845504/t)

**2.** **å¾ªç¯è‚¿ç˜¤ DNA æ°´å¹³å¯¹å‚åŠ  plasmaMATCH è¯•éªŒçš„æ™šæœŸä¹³è…ºç™Œæ‚£è€…çš„é¢„åå’Œé¢„æµ‹å½±å“**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤
- ğŸ“ **æè¿°**ï¼šSecret hovertext: ç›®çš„ï¼šå¾ªç¯è‚¿ç˜¤ DNA ï¼ˆctDNAï¼‰ åŠ¨æ€æ°´å¹³å¯ä»¥è¯†åˆ«å¯¹æ²»ç–—æœ‰ååº”çš„æ‚£è€…ã€‚æˆ‘ä»¬åœ¨ plasmaMATCH è¯•éªŒä¸­è¯„ä¼°äº†æ™šæœŸä¹³è…ºç™Œæ‚£è€…çš„ ctDNA åŸºçº¿æ°´å¹³å’Œæ²»ç–—åŠ¨æ€ï¼Œé‡‡ç”¨çªå˜é¶å‘æ²»ç–—ï¼ˆé˜Ÿåˆ— A-Dï¼‰å’Œä¸‰é˜´æ€§ä¹³è…ºç™Œ ï¼ˆTNBCï¼‰ è”åˆä½¿ç”¨å¥¥æ‹‰å¸•å°¼å’Œ ceralasertibï¼ˆé˜Ÿåˆ— Eï¼‰ã€‚å®éªŒè®¾è®¡ï¼šåœ¨åŸºçº¿ï¼ˆC1D1ï¼‰å’Œæ²»ç–—å‰çš„ç¬¬ 2 å¤©ï¼ˆC2D1ï¼‰é‡‡é›†è¡€æ ·ã€‚ä½¿ç”¨çº é”™çš„é¶å‘ç»„åˆï¼ˆGuardant360/GuardantOMNIï¼‰å¯¹æ ·å“è¿›è¡Œæµ‹åºã€‚å¾ªç¯ DNA æ¯”å€¼ï¼ˆCDRï¼‰è®¡ç®—ä¸º C2D1/C1D1 çš„æ¯”å€¼ã€‚CDR å’ŒåŸºçº¿ ctDNA æ°´å¹³ä¸æ— è¿›å±•ç”Ÿå­˜æœŸ ï¼ˆPFSï¼‰ å’Œç¡®è®¤å®¢è§‚ç¼“è§£ç‡ ï¼ˆORRï¼‰ ç›¸å…³ã€‚ç»“æœï¼š167 åæ‚£è€…å…·æœ‰å¯è¯„ä¼°çš„ C1D1-C2D1 ctDNA ç»“æœã€‚é˜Ÿåˆ— E çš„åŸºçº¿ ctDNA æ°´å¹³ä¸ååº”ä¹‹é—´å­˜åœ¨å¾ˆå¼ºçš„å…³è”;åŸºçº¿æ°´å¹³ä½ä¸ PFS è¾ƒé•¿ï¼ˆHR 0.33ï¼Œp=0.001ï¼‰å’Œè¾ƒé«˜çš„
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://m.x-mol.com/paper/1983669139932999680/t)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰

**1.** **Â¿QuÃ© es el Ãndice de Gini y cÃ³mo calcularlo?**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šscDNA
- ğŸ“ **æè¿°**ï¼šIf this post is useful to you I kindly ask a minimal donation on Buy Me a Coffee. It shall be used to continue my Open Source efforts. You can send me questions for the blog using this form and subscribe to receive an email when there is a new ... Continue reading: Â¿QuÃ© es el Ãndice de Gini y cÃ³mo calcularlo?
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.r-bloggers.com/2025/10/que-es-el-indice-de-gini-y-como-calcularlo/)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰

**1.** â­ **Single-Cell Splicing EStimation â€“ deciphering splicing heterogeneity at single-cell resolution**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€Scanpyã€epigeneticã€histone
- ğŸ“ **æè¿°**ï¼šResearchers developed SCSES, a computational tool that enhances RNA sequencing data by accurately detecting alternative splicing and revealing hidden cellular diversity...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/single-cell-splicing-estimation-deciphering-splicing-heterogeneity-at-single-cell-resolution/)

**2.** â­ **RNA sequencing reveals age-related changes in T cells that weaken vaccine responses**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€sequencingã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€Seuratã€histone
- ğŸ“ **æè¿°**ï¼šResearchers used single-cell RNA sequencing to reveal how aging alters T cell function, explaining weaker vaccine responses in older adults and guiding future vaccine innovations...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/how-rna-sequencing-reveals-age-related-changes-in-t-cells-that-weaken-vaccine-responses/)

**3.** â­ **sysVI â€“ integrating single-cell RNA-seq datasets with substantial batch effects**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šRNA-seqã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATAC
- ğŸ“ **æè¿°**ï¼šResearchers at Helmholtz Munich developed sysVI, a machine learning method that improves integration of RNA sequencing data across diverse systems while preserving vital...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/sysvi-integrating-single-cell-rna-seq-datasets-with-substantial-batch-effects/)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| scRNA | 15 |
| scDNA | 15 |
| cancer | 13 |
| genome | 13 |
| scATAC | 12 |
| Seurat | 9 |
| spatial | 9 |
| histone | 8 |
| genomics | 8 |
| proteome | 8 |
| single.cell | 7 |
| tumor | 7 |
| å•ç»†èƒ | 6 |
| è‚¿ç˜¤ | 6 |
| Hi-C | 6 |
| carcinoma | 6 |
| single-cell | 5 |
| Scanpy | 5 |
| epigenome | 5 |
| epigenetic | 4 |

---

## ğŸ“ æ›´å¤šå†…å®¹

<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (1æ¡)</summary>

<div class="details-content" markdown="1">

- [ä»â€œåŸºå› æ²‰é»˜â€åˆ°â€œåŸºå› ç»„å®ˆæŠ¤â€ï¼šä»»æ·ç­‰æ­ç¤ºDicerä½œä¸ºåˆ†å­æ¢çº½ï¼Œåè°ƒè½¬å½•ã€å¤åˆ¶ä¸ä¿®å¤ | Cell Pressè®ºæ–‡é€Ÿé€’](https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&mid=2247656588&idx=3&sn=1fc68ed0f4e3e18b9549b584adb7662b)

</div>

</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (4æ¡)</summary>

<div class="details-content" markdown="1">

- [GSE254563 Podocyte Twin in Culture: Patient-specific ex vivo Model of Genetic FSGS caused by an INF2 Mutation](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254563)
- [GSE304835 Transcriptomic profiling of DHA-treated human chondrocytes](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304835)
- [GSE263443 Gene expression profile at single cell level of CD11b+ cells from E18.5 fetal brain](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263443)
- [GSE289801 Effect of FBL depletion on cell morphology](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289801)

</div>

</details>

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-10-31 21:37*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*